260 related articles for article (PubMed ID: 26661062)
1. Galanin inhibits GLP-1 and GIP secretion via the GAL1 receptor in enteroendocrine L and K cells.
Psichas A; Glass LL; Sharp SJ; Reimann F; Gribble FM
Br J Pharmacol; 2016 Mar; 173(5):888-98. PubMed ID: 26661062
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor 5 and cannabinoid receptor 1 activation inhibit secretion of glucose-dependent insulinotropic polypeptide from intestinal K cells in rodents.
Moss CE; Marsh WJ; Parker HE; Ogunnowo-Bada E; Riches CH; Habib AM; Evans ML; Gribble FM; Reimann F
Diabetologia; 2012 Nov; 55(11):3094-103. PubMed ID: 22872212
[TBL] [Abstract][Full Text] [Related]
3. Galanin inhibits glucagon-like peptide-1 secretion through pertussis toxin-sensitive G protein and ATP-dependent potassium channels in rat ileal L-cells.
Saïfia S; Chevrier AM; Bosshard A; Cuber JC; Chayvialle JA; Abello J
J Endocrinol; 1998 Apr; 157(1):33-41. PubMed ID: 9614355
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves.
Mayer F; Gunawan AL; Tso P; Aponte GW
Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G23-G35. PubMed ID: 32421358
[TBL] [Abstract][Full Text] [Related]
5. Fructose stimulates GLP-1 but not GIP secretion in mice, rats, and humans.
Kuhre RE; Gribble FM; Hartmann B; Reimann F; Windeløv JA; Rehfeld JF; Holst JJ
Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(7):G622-30. PubMed ID: 24525020
[TBL] [Abstract][Full Text] [Related]
6. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
[TBL] [Abstract][Full Text] [Related]
7. Chylomicrons stimulate incretin secretion in mouse and human cells.
Psichas A; Larraufie PF; Goldspink DA; Gribble FM; Reimann F
Diabetologia; 2017 Dec; 60(12):2475-2485. PubMed ID: 28866808
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose.
Damholt AB; Buchan AM; Kofod H
Endocrinology; 1998 Apr; 139(4):2085-91. PubMed ID: 9528997
[TBL] [Abstract][Full Text] [Related]
9. Lipid derivatives activate GPR119 and trigger GLP-1 secretion in primary murine L-cells.
Hodge D; Glass LL; Diakogiannaki E; Pais R; Lenaghan C; Smith DM; Wedin M; Bohlooly-Y M; Gribble FM; Reimann F
Peptides; 2016 Mar; 77():16-20. PubMed ID: 26144594
[TBL] [Abstract][Full Text] [Related]
10. Intestinal Gpr17 deficiency improves glucose metabolism by promoting GLP-1 secretion.
Yan S; Conley JM; Reilly AM; Stull ND; Abhyankar SD; Ericsson AC; Kono T; Molosh AI; Kubal CA; Evans-Molina C; Ren H
Cell Rep; 2022 Jan; 38(1):110179. PubMed ID: 34986353
[TBL] [Abstract][Full Text] [Related]
11. Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats.
Wang JH; Inoue T; Higashiyama M; Guth PH; Engel E; Kaunitz JD; Akiba Y
J Pharmacol Exp Ther; 2011 Nov; 339(2):464-73. PubMed ID: 21846840
[TBL] [Abstract][Full Text] [Related]
12. Studies with GIP/Ins cells indicate secretion by gut K cells is KATP channel independent.
Wang SY; Chi MM; Li L; Moley KH; Wice BM
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E988-1000. PubMed ID: 12676650
[TBL] [Abstract][Full Text] [Related]
13. Role of enteroendocrine L-cells in arginine vasopressin-mediated inhibition of colonic anion secretion.
Pais R; Rievaj J; Meek C; De Costa G; Jayamaha S; Alexander RT; Reimann F; Gribble F
J Physiol; 2016 Sep; 594(17):4865-78. PubMed ID: 27037495
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of incretin secretion by dietary lipid: is it dose dependent?
Yoder SM; Yang Q; Kindel TL; Tso P
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G299-305. PubMed ID: 19520739
[TBL] [Abstract][Full Text] [Related]
15. Novel extrapancreatic effects of incretin.
Yamada Y; Tsukiyama K; Sato T; Shimizu T; Fujita H; Narita T
J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):76-9. PubMed ID: 27186360
[TBL] [Abstract][Full Text] [Related]
16. Nesfatin-1 stimulates glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide secretion from STC-1 cells in vitro.
Ramesh N; Mortazavi S; Unniappan S
Biochem Biophys Res Commun; 2015 Jun; 462(2):124-30. PubMed ID: 25930999
[TBL] [Abstract][Full Text] [Related]
17. Selective release of gastrointestinal hormones induced by an orally active GPR39 agonist.
Grunddal KV; Diep TA; Petersen N; Tough IR; Skov LJ; Liu L; Buijink JA; Mende F; Jin C; Jepsen SL; Sørensen LME; Achiam MP; Strandby RB; Bach A; Hartmann B; Frimurer TM; Hjorth SA; Bouvier M; Cox H; Holst B
Mol Metab; 2021 Jul; 49():101207. PubMed ID: 33711555
[TBL] [Abstract][Full Text] [Related]
18. Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells.
Parker HE; Habib AM; Rogers GJ; Gribble FM; Reimann F
Diabetologia; 2009 Feb; 52(2):289-298. PubMed ID: 19082577
[TBL] [Abstract][Full Text] [Related]
19. GLP1- and GIP-producing cells rarely overlap and differ by bombesin receptor-2 expression and responsiveness.
Svendsen B; Pais R; Engelstoft MS; Milev NB; Richards P; Christiansen CB; Egerod KL; Jensen SM; Habib AM; Gribble FM; Schwartz TW; Reimann F; Holst JJ
J Endocrinol; 2016 Jan; 228(1):39-48. PubMed ID: 26483393
[TBL] [Abstract][Full Text] [Related]
20. Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility.
Miki T; Minami K; Shinozaki H; Matsumura K; Saraya A; Ikeda H; Yamada Y; Holst JJ; Seino S
Diabetes; 2005 Apr; 54(4):1056-63. PubMed ID: 15793244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
